SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs.

A completely new approach to drug discovery and development.

FDA cleared IND for open-label, Phase 1b, 30-subject trial of SFA002 in Mild to Moderate Psoriasis

29 June 2020

Our Latest News

CONTACT US

Fill this Form to Get More Information

SFA Therapeutics

610 Old York Rd, Suite 400, Jenkintown, Pennsylvania 19046, United States

info@sfatherapeutics.com
267-584-1080